Cite
HARVARD Citation
Tustumi, F. et al. (2022). 18F-FDG PET/CT after neoadjuvant chemoradiotherapy in patients with esophageal carcinoma as a potential predictor of residual disease.. European journal of surgical oncology. 48 (2), pp. e181-e182. [Online].